AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31453531 — intervention group
Group type: EXPERIMENTAL
Intervention: SPRI-L (land-based intervention)
Number of subjects: 73
Study 27048333 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 43
Study 27048333 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 25753825 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomic Ligament Repair (ALR)
Number of subjects: 64
Study 25753825 — intervention group
Group type: EXPERIMENTAL
Intervention: Triangular Ligament Reconstruction (TLR)
Number of subjects: 64
Study 23857248 — intervention group
Group type: EXPERIMENTAL
Intervention: Preladenant 10 mg BID for 5 days
Number of subjects: 60
Study 23857248 — intervention group
Group type: EXPERIMENTAL
Intervention: Preladenant 100 mg BID for 5 days
Number of subjects: 60
Study 23857248 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg on day 5
Number of subjects: 60
Study 23857248 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 19952825 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate extract (POMx)
Number of subjects: 0
Study 19952825 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 0
Study 18823310 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus strain GG (LGG) treatment
Number of subjects: 73
Study 18823310 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus strain GG (LGG) treatment in adults
Number of subjects: 73
Study 16082393 — intervention group
Group type: EXPERIMENTAL
Intervention: Schirmer's test (cutoff point of 5 mm)
Number of subjects: 103
Study 16082393 — intervention group
Group type: EXPERIMENTAL
Intervention: Schirmer's test (cutoff point of 10 mm)
Number of subjects: 103
Study 16082393 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenol red thread test (cutoff point of 10 mm)
Number of subjects: 103
Study 16082393 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenol red thread test (cutoff point of 20 mm)
Number of subjects: 103
Study 16082393 — intervention group
Group type: EXPERIMENTAL
Intervention: Agreement between Schirmer's test and phenol red thread test
Number of subjects: 103
Study 16082393 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptoms of dry eyes
Number of subjects: 103
Study 12631257 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate 90 mg
Number of subjects: 44
Study 12631257 — intervention group
Group type: COMPARATOR
Intervention: Ibandronate 4 mg
Number of subjects: 44
Study 12631257 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 44
Study 10994765 — intervention group
Group type: EXPERIMENTAL
Intervention: High-calcium skim milk
Number of subjects: 38
Study 10994765 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium-enriched high-calcium skim milk
Number of subjects: 38
Study 10994765 — intervention group
Group type: COMPARATOR
Intervention: Skim milk (control)
Number of subjects: 38
Study 8557126 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting GnRH analogues
Number of subjects: 100
Study 8557126 — intervention group
Group type: COMPARATOR
Intervention: Short-acting GnRH analogues
Number of subjects: 100
Study 1587405 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical acustimulation
Number of subjects: 61
Study 1587405 — intervention group
Group type: COMPARATOR
Intervention: Sham acustimulation
Number of subjects: 61
Study 1587405 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 61
Study 3159583 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg ketanserin
Number of subjects: 6
Study 3159583 — intervention group
Group type: COMPARATOR
Intervention: Placebo (10 ml saline)
Number of subjects: 6
Study 31166976 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (initiated at 300 mg/day, titrated to a maximum of 1800 mg/day)
Number of subjects: 98
Study 31166976 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 31166976 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 98
Study 29626068 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 22351
Study 27086024 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tacrolimus 0.05%
Number of subjects: 40
Study 27086024 — intervention group
Group type: COMPARATOR
Intervention: Topical methylprednisolone 0.5%
Number of subjects: 40
Study 24096438 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-balloon catheter
Number of subjects: 0
Study 24096438 — intervention group
Group type: COMPARATOR
Intervention: Dinoprostone (10-mg intra-vaginal insert)
Number of subjects: 0
Study 23128405 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative selective decontamination of the digestive tract (SDD)
Number of subjects: 289
Study 23128405 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 289
Study 20826630 — intervention group
Group type: EXPERIMENTAL
Intervention: GLUFRU (1.2 g glucose/min + 0.8 g fructose/min)
Number of subjects: 7
Study 20826630 — intervention group
Group type: COMPARATOR
Intervention: Glucose alone (1.2 g glucose/min)
Number of subjects: 7
Study 18617257 — intervention group
Group type: EXPERIMENTAL
Intervention: 10,000 Steps Ghent intervention
Number of subjects: 440
Study 18617257 — intervention group
Group type: EXPERIMENTAL
Intervention: 10,000 Steps Ghent intervention (participants who increased step counts)
Number of subjects: 440
Study 18617257 — intervention group
Group type: EXPERIMENTAL
Intervention: 10,000 Steps Ghent intervention (participants who did not increase step counts)
Number of subjects: 440
Study 18617257 — intervention group
Group type: COMPARATOR
Intervention: Comparison community
Number of subjects: 440
Study 15968765 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV) immediately post-operatively
Number of subjects: 0
Study 15968765 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 12087347 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (100, 250, and 1000 ng/min) with placebo
Number of subjects: 0
Study 12087347 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (100, 250, and 1000 ng/min) with angiotensin II at 1 pmol/min
Number of subjects: 0
Study 12087347 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (100, 250, and 1000 ng/min) with angiotensin II at 5 pmol/min
Number of subjects: 0
Study 12087347 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan (single dose) or vitamin C (coinfusion)
Number of subjects: 0
Study 10689211 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily cefdinir 600 mg
Number of subjects: 1045
Study 10689211 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily cefdinir 300 mg
Number of subjects: 1045
Study 10689211 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily cefuroxime axetil 250 mg
Number of subjects: 1045
Study 9034133 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkali (NaHCO3)
Number of subjects: 8
Study 9034133 — intervention group
Group type: COMPARATOR
Intervention: Placebo (NaCl)
Number of subjects: 8
Study 8477290 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrained eaters under anxiety
Number of subjects: 0
Study 8477290 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrained eaters under relaxed conditions
Number of subjects: 0
Study 8477290 — intervention group
Group type: COMPARATOR
Intervention: Unrestrained eaters
Number of subjects: 0
Study 8477290 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxious hungry restrained subjects
Number of subjects: 0
Study 3520389 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion with micropump CPI 9100 Lilly
Number of subjects: 10
Study 3520389 — intervention group
Group type: COMPARATOR
Intervention: Intensified insulin therapy with three daily doses of MC rapid insulin, two of which associated with MC intermediate insulin
Number of subjects: 10
Study 28617962 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive discourse with affirmative and negative sentences
Number of subjects: 44
Study 28617962 — intervention group
Group type: EXPERIMENTAL
Intervention: Blocked presentation of affirmative and negative sentences (affirmatives first)
Number of subjects: 44
Study 28617962 — intervention group
Group type: COMPARATOR
Intervention: Randomized sentence types
Number of subjects: 44
Study 27473777 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative wound complications (WCs)
Number of subjects: 500
Study 27473777 — intervention group
Group type: COMPARATOR
Intervention: No complication (NC)
Number of subjects: 500
Study 27473777 — intervention group
Group type: EXPERIMENTAL
Intervention: Claudication subgroup
Number of subjects: 500
Study 27473777 — intervention group
Group type: EXPERIMENTAL
Intervention: Rest pain and tissue loss groups
Number of subjects: 500
Study 27473777 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal aortic aneurysm cohort
Number of subjects: 500
Study 24531203 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-Intensity Interval Training (HIIT)
Number of subjects: 39
Study 24531203 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MCT)
Number of subjects: 39
Study 23067923 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based self-management program with home blood pressure cuff
Number of subjects: 404
Study 23067923 — intervention group
Group type: COMPARATOR
Intervention: Onsite blood pressure cuff (Control)
Number of subjects: 404
Study 20136766 — intervention group
Group type: EXPERIMENTAL
Intervention: Football training program
Number of subjects: 22
Study 20136766 — intervention group
Group type: COMPARATOR
Intervention: Standard exercise program
Number of subjects: 22
Study 18981463 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT-510 20 mg once a day
Number of subjects: 88
Study 18981463 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT-510 100 mg twice a day
Number of subjects: 88
Study 15653656 — intervention group
Group type: EXPERIMENTAL
Intervention: (90)Y-DOTATOC
Number of subjects: 65
Study 15653656 — intervention group
Group type: EXPERIMENTAL
Intervention: (177)Lu-DOTATATE
Number of subjects: 65
Study 12207594 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) 2 g kg‐1, administered as an 8‐h infusion of 1 g kg‐1 daily for two consecutive days
Number of subjects: 10
Study 12207594 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment with IVIG (control group)
Number of subjects: 10
Study 10587392 — intervention group
Group type: EXPERIMENTAL
Intervention: Dacron bypass graft
Number of subjects: 419
Study 10587392 — intervention group
Group type: COMPARATOR
Intervention: Polytetrafluoroethylene bypass graft
Number of subjects: 419
Study 8903550 — intervention group
Group type: EXPERIMENTAL
Intervention: Burch colposuspension
Number of subjects: 51
Study 8903550 — intervention group
Group type: COMPARATOR
Intervention: Stamey endoscopic bladder neck suspension
Number of subjects: 51
Study 1758315 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted instruction (CAI)
Number of subjects: 35
Study 1758315 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of seminar teaching and audiotapes
Number of subjects: 35
Study 1758315 — intervention group
Group type: COMPARATOR
Intervention: Seminar teaching plus audiotapes
Number of subjects: 35
Study 1758315 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of CAI and seminar teaching
Number of subjects: 35
Study 31894026 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed combined with platinum drugs and evidence‐based nursing mode
Number of subjects: 200
Study 31894026 — intervention group
Group type: COMPARATOR
Intervention: Pemetrexed therapy and routine nursing mode
Number of subjects: 200
Study 28271312 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling with superimposed EMS (C + E)
Number of subjects: 21
Study 28271312 — intervention group
Group type: COMPARATOR
Intervention: Cycling (C)
Number of subjects: 21
Study 25935433 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 minutes of moderate-intensity exercise on a treadmill
Number of subjects: 14
Study 25935433 — intervention group
Group type: COMPARATOR
Intervention: 30 minutes of rest
Number of subjects: 14
Study 23665341 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvanted vaccines (30 μg, 60 μg, 90 μg)
Number of subjects: 300
Study 23665341 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 μg adjuvanted formulation
Number of subjects: 300
Study 23665341 — intervention group
Group type: EXPERIMENTAL
Intervention: All doses and formulations
Number of subjects: 300
Study 23665341 — intervention group
Group type: COMPARATOR
Intervention: Non-adjuvanted vaccines (30 μg, 60 μg, 90 μg)
Number of subjects: 300
Study 21430645 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 50 mg
Number of subjects: 16
Study 21430645 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 200 mg
Number of subjects: 16
Study 21430645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 19225432 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear sunglasses
Number of subjects: 69
Study 19225432 — intervention group
Group type: EXPERIMENTAL
Intervention: Gray sunglasses
Number of subjects: 69
Study 19225432 — intervention group
Group type: EXPERIMENTAL
Intervention: Green sunglasses
Number of subjects: 69
Study 19225432 — intervention group
Group type: EXPERIMENTAL
Intervention: Yellow-green sunglasses
Number of subjects: 69
Study 19225432 — intervention group
Group type: EXPERIMENTAL
Intervention: Yellow-brown sunglasses
Number of subjects: 69
Study 19225432 — intervention group
Group type: EXPERIMENTAL
Intervention: Red-brown sunglasses
Number of subjects: 69
Study 19225432 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tint
Number of subjects: 69
Study 17723807 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-down tilt group (n = 17)
Number of subjects: 34
Study 17723807 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 17)
Number of subjects: 34
Study 15151685 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste containing 1450 ppm F
Number of subjects: 3467
Study 15151685 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste containing 440 ppm F
Number of subjects: 3467
Study 15151685 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (no intervention)
Number of subjects: 3467
Study 15151685 — intervention group
Group type: EXPERIMENTAL
Intervention: Both low- and high-fluoride toothpaste
Number of subjects: 3467
Study 11794040 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT (oestrogen)
Number of subjects: 2016
Study 11794040 — intervention group
Group type: COMPARATOR
Intervention: No HRT
Number of subjects: 2016
Study 9868662 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone 2 g once daily for 4 weeks
Number of subjects: 61
Study 9868662 — intervention group
Group type: COMPARATOR
Intervention: Ceftriaxone 2 g plus gentamicin 3 mg/kg once daily for 2 weeks
Number of subjects: 61
Study 8027914 — intervention group
Group type: EXPERIMENTAL
Intervention: Residential treatment for 2 years
Number of subjects: 50
Study 2528705 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylstilboestrol (DES)
Number of subjects: 92
Study 791194 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg maprotiline per day
Number of subjects: 20
Study 791194 — intervention group
Group type: EXPERIMENTAL
Intervention: 225 mg maprotiline per day
Number of subjects: 20
Study 791194 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg maprotiline per day (initial dosage for first 2 days)
Number of subjects: 20
Study 30377712 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine (9 g/day) for 6 weeks
Number of subjects: 20
Study 30377712 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 30377712 — intervention group
Group type: EXPERIMENTAL
Intervention: Skeletal muscle biopsies
Number of subjects: 20
Study 28292574 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-containing lubricant eye drop (Systane® Balance)
Number of subjects: 50
Study 28292574 — intervention group
Group type: EXPERIMENTAL
Intervention: Phospholipid liposomal spray (Tears Again®)
Number of subjects: 50
Study 26188837 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral solution of apixaban 10 mg
Number of subjects: 3
Study 26188837 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral solution via NGT flushed with D5W
Number of subjects: 3
Study 26188837 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral solution via NGT flushed with infant formula
Number of subjects: 3
Study 26188837 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral solution via NGT with nutritional supplement
Number of subjects: 3
Study 26188837 — intervention group
Group type: EXPERIMENTAL
Intervention: Crushed tablet suspended in D5W via NGT
Number of subjects: 3
Study 26188837 — intervention group
Group type: COMPARATOR
Intervention: Oral solution of apixaban 5 mg
Number of subjects: 3
Study 26188837 — intervention group
Group type: COMPARATOR
Intervention: Crushed tablet via NGT
Number of subjects: 3
Study 23252829 — intervention group
Group type: EXPERIMENTAL
Intervention: Tangible reward (sticker)
Number of subjects: 137
Study 23252829 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal reward (praise)
Number of subjects: 137
Study 23252829 — intervention group
Group type: EXPERIMENTAL
Intervention: No reward
Number of subjects: 137
Study 23252829 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 137
Study 21228739 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin stretching device for wound closure
Number of subjects: 30
Study 21228739 — intervention group
Group type: COMPARATOR
Intervention: Scar excision without additional techniques (control)
Number of subjects: 30
Study 18309164 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic mezlocillin plus sulbactam (3 x 2 g/1 g for 4 days)
Number of subjects: 60
Study 18309164 — intervention group
Group type: COMPARATOR
Intervention: Conventional management
Number of subjects: 60
Study 16877734 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel 60 mg/m2 (day 1) every 21 days for four cycles
Number of subjects: 182
Study 16877734 — intervention group
Group type: COMPARATOR
Intervention: Vinorelbine 25 mg/m2 (days 1 and 8) every 21 days for four cycles
Number of subjects: 182
Study 16877734 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel
Number of subjects: 182
Study 16877734 — intervention group
Group type: COMPARATOR
Intervention: Vinorelbine
Number of subjects: 182
Study 12917503 — intervention group
Group type: EXPERIMENTAL
Intervention: High-CHO diet (58% of energy as carbohydrates)
Number of subjects: 63
Study 12917503 — intervention group
Group type: EXPERIMENTAL
Intervention: High-MUFA diet (40% of energy as fat, 23% as MUFAs)
Number of subjects: 63
Study 11194957 — intervention group
Group type: EXPERIMENTAL
Intervention: Locoregional irradiation after mastectomy
Number of subjects: 7840
Study 11194957 — intervention group
Group type: EXPERIMENTAL
Intervention: Modern radiotherapy
Number of subjects: 7840
Study 9013263 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E 400 mg once a day orally for 4 weeks
Number of subjects: 20
Study 9013263 — intervention group
Group type: COMPARATOR
Intervention: Pre-treatment state
Number of subjects: 20
Study 9013263 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart failure patients with ejection fraction < 40%
Number of subjects: 20
Study 1394580 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized pilocarpine
Number of subjects: 25
Study 1394580 — intervention group
Group type: COMPARATOR
Intervention: Histamine alone
Number of subjects: 25
Study 3890159 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid injections
Number of subjects: 0
Study 3890159 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29759061 — intervention group
Group type: EXPERIMENTAL
Intervention: TAP block with 20 ml 0.375% ropivacaine
Number of subjects: 139
Study 27449358 — intervention group
Group type: COMPARATOR
Intervention: Comprehensive (Family Healthy Lifestyle plus Family Recreation programs)
Number of subjects: 1168
Study 27449358 — intervention group
Group type: COMPARATOR
Intervention: Family Healthy Lifestyle
Number of subjects: 1168
Study 27449358 — intervention group
Group type: COMPARATOR
Intervention: Family Recreation
Number of subjects: 1168
Study 27449358 — intervention group
Group type: COMPARATOR
Intervention: Self-Directed (no intervention)
Number of subjects: 1168
Study 24708394 — intervention group
Group type: EXPERIMENTAL
Intervention: Small graft group (FGG thickness <2 mm, height 4 mm)
Number of subjects: 60
Study 24708394 — intervention group
Group type: COMPARATOR
Intervention: Big graft group (FGG thickness ≥ 2 mm, height equal to bone dehiscence)
Number of subjects: 60
Study 22230323 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg/d
Number of subjects: 6766
Study 22230323 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6766
Study 22230323 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin (genetic association)
Number of subjects: 6766
Study 22230323 — intervention group
Group type: COMPARATOR
Intervention: Placebo (genetic association)
Number of subjects: 6766
Study 20723849 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 2530
Study 20723849 — intervention group
Group type: COMPARATOR
Intervention: UFH plus GPI
Number of subjects: 2530
Study 19006764 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal abduction (32.6N)
Number of subjects: 21
Study 19006764 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal adduction (42.4N)
Number of subjects: 21
Study 19006764 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifinger performance
Number of subjects: 21
Study 19006764 — intervention group
Group type: EXPERIMENTAL
Intervention: Coordination of AbAd
Number of subjects: 21
Study 16192478 — intervention group
Group type: EXPERIMENTAL
Intervention: DrotAA (24 microg/kg/hour for 96 hours)
Number of subjects: 2613
Study 16192478 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2613
Study 14675884 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg/day) + ACE inhibitor (lisinopril 5 mg/day)
Number of subjects: 56
Study 14675884 — intervention group
Group type: COMPARATOR
Intervention: ACE inhibitor (lisinopril 5 mg/day) alone
Number of subjects: 56
Study 10982926 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioefficient Therapy
Number of subjects: 90